Professor, Internal Medicine, University of Texas Medical School, Houston
Infectious Disease
Dr. Pablo C. Okhuysen, MD
|
|
Give Review
Doctor Pablo C. Okhuysen, MD works in the field of Infectious Disease. Pablo C. Okhuysen, MD has written publications. He has 100 publications published with PubMed. The lastest publication is: 'Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Cryptosporidium muris: Infectivity and Illness in Healthy Adult Volunteers.
- Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals?
- Persistent Abdominal Symptoms in US Adults After Short-Term Stay in Mexico.
- Seroepidemiology of norovirus-associated travelers' diarrhea.
- Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.
- A Randomized, Double-Blind, Pilot Study of Rifaximin 550 mg Versus Placebo in the Prevention of Travelers' Diarrhea in Mexico During the Dry Season.
- Cryptosporidium meleagridis: Infectivity in Healthy Adult Volunteers.
- Single Nucleotide Polymorphisms in the Promoter of the Gene Encoding the Lipopolysaccharide Receptor CD14 Are Associated With Bacterial Diarrhea in US and Canadian Tra...
- Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico.
- Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.
- Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance.
- Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007.
- Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.
- Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.
- Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
- Genetics of susceptibility to infection with enteric pathogens.
- A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia co...
- Enteroaggregative Escherichia coli infection.
- A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen.
- Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the Un...
- Epidemiology of cryptosporidiosis in North American travelers to Mexico.
- PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea.
- Cryptosporidium muris in a Texas canine population.
- Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
- A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico.
- Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries.
- High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity.
- Cryptosporidium hominis: experimental challenge of healthy adults.
- Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis.
- Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses.
- Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico.
- Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment.
- Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin.
- A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
- A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
- Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies.
- Cryptosporidiosis in children.
- Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.
- Molecular epidemiology of the fsr locus and of gelatinase production among different subsets of Enterococcus faecalis isolates.
- Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli.
- Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocysts.
- Enteroaggregative Escherichia coli: an emerging enteric pathogen.
- Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis.
- Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.
- Substance P expression correlates with severity of diarrhea in cryptosporidiosis.
- Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis.
- Cryptosporidiosis.
- HIV1 and the gut in the era of highly active antiretroviral therapy.
- Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae.
- Cryptosporidium dose-response studies: variation between hosts.
- Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice.
- Cryptosporidium dose response studies: variation between isolates.
- Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience.
- Use of a patch containing heat-labile toxin from Escherichia coli against travellers'' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
- Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
- Molecular cloning and analysis of the Cryptosporidium parvum aminopeptidase N gene.
- Loperamide plus azithromycin more effectively treats travelers'' diarrhea in Mexico than azithromycin alone.
- Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.
- Cryptosporidium virulence determinants--are we there yet?
- Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study.
- Rifaximin treatment of pathogen-negative travelers'' diarrhea.
- Cryptosporidium parvum: identification and characterization of an acid phosphatase.
- A review of an emerging enteric pathogen: enteroaggregative Escherichia coli.
- Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects.
- A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea.
- Risk assessment for Cryptosporidium: a hierarchical Bayesian analysis of human dose response data.
- Travelers' diarrhea. Prevention and treatment.
- A comparative study of furazolidone and placebo in addition to oral rehydration in the treatment of acute infantile diarrhea.
- The infectivity of Cryptosporidium parvum in healthy volunteers.
- Viral shedding and fecal IgA response after Norwalk virus infection.
- Arginine aminopeptidase, an integral membrane protein of the Cryptosporidium parvum sporozoite.
- Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans.
- Susceptibility of beta-lactamase-producing enterococci to piperacillin with tazobactam.
- St. Louis encephalitis in patients with human immunodeficiency virus infection.
- Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers.
- Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial.
- Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation.
- Paradoxical subcutaneous tuberculous abscess.
- Flow cytometric detection of Cryptosporidium oocysts in human stool samples.
- Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.
- Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum.
- The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans.
- Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G.
- Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.
- Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.
- Fecal antibodies to Cryptosporidium parvum in healthy volunteers.
- Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.
- Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with expos...
- Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution.
- Traveler's diarrhea due to intestinal protozoa.
- Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.
- Pharmacokinetic and other drug interactions in patients with AIDS.
- Characterization of a cytosolic aminopeptidase from Encephalitozoon intestinalis.
- Parasitic infections of the intestines.
- Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
- In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
- Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
- Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial.
- Characterization of norovirus-associated traveler's diarrhea.
Schools
Universidad Autonoma De Guadalajara Facultad De Medicina
Cook Co Hospital
University Texas
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Texas Health Science Center -
John H. Stroger Hospital of Cook County -
Universidad Autonoma de Guadalajara
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1629096987 | |
| NPPES Provider LastName | OKHUYSEN | |
| NPPES Provider FirstName | PABLO | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 188.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629096987 |
| Last Name Of The Provider | OKHUYSEN |
| First Name Of The Provider | PABLO |
| View All |
Similar Doctors
|
Dr. Temple W. Williams Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Barry J. Zeluff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Layne O. Gentry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy F. Chemaly, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rajendra G. Pandya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Coralia N. Mihu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley Drews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nizar A. Dholakia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto C. Arduino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aline M. El Zakhem, MD |
|
|
Dr. Syed W. Hasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad F. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meena Sunil, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward R. Rensimer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberto Andrade, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Hamill, MD
This Doctor is OpenDoctor Recommended.
|